Literature DB >> 8547021

Dystrophic form of inherited epidermolysis bullosa in a dog (Akita Inu).

M Nagata1, H Shimizu, T Masunaga, T Nishikawa, H Nanko, K Kariya, T Washizu, T Ishida.   

Abstract

We report a dog with dystrophic epidermolysis bullosa. This 4-year-old female Akita Inu, a species of Canis familiaris var. japonicus Temminck, had a 3-year-history of ulcers and scars over the pressure areas on the limbs, and dystrophic nails, since the age of 1 year, which corresponds to early adulthood in humans. Electron microscopy of a blister revealed separation beneath the lamina densa, and a reduction in the number of anchoring fibrils. The NC-1 domain of type VII collagen was positively stained with monoclonal antibody LH7.2 at the basement membrane zone. These findings indicate that humans and dogs have a similar response to antibody LH7.2, which may aid the development of an animal model for this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547021     DOI: 10.1111/j.1365-2133.1995.tb06942.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

Authors:  Jason A Bubier; Thomas J Sproule; Lydia M Alley; Cameron M Webb; Jo-David Fine; Derry C Roopenian; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-03-25       Impact factor: 8.551

2.  A COL7A1 Variant in a Litter of Neonatal Basset Hounds with Dystrophic Epidermolysis Bullosa.

Authors:  Teresa Maria Garcia; Sarah Kiener; Vidhya Jagannathan; Duncan S Russell; Tosso Leeb
Journal:  Genes (Basel)       Date:  2020-12-04       Impact factor: 4.096

Review 3.  Inheritance of Monogenic Hereditary Skin Disease and Related Canine Breeds.

Authors:  Pablo Jesús Marín-García; Lola Llobat
Journal:  Vet Sci       Date:  2022-08-15

4.  Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.

Authors:  Alexander Nyström; Jens Buttgereit; Michael Bader; Tatiana Shmidt; Cemil Ozcelik; Ingrid Hausser; Leena Bruckner-Tuderman; Johannes S Kern
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.